Glucotrack (GCTK) Equity Ratio (2010 - 2025)

Glucotrack has disclosed Equity Ratio across 16 years of filings, most recently posting 0.36 for Q4 2025.

• Quarterly Equity Ratio rose 116.46% year-over-year to 0.36 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.36 (up 116.46% YoY) and the FY2025 annual result came in at 0.36, up 116.46% from the prior year.
• Equity Ratio advanced to 0.36 in Q4 2025, from 0.33 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.86 in Q2 2023 and troughed at 5.41 in Q2 2024.
• A 5-year average of 0.09 and a median of 0.67 in 2022 frame the typical range for Equity Ratio.
• Biggest YoY gain for Equity Ratio was 1925.06% in 2024; the steepest drop was 730.45% in 2024.
• Tracing GCTK's Equity Ratio over 5 years: stood at 0.82 in 2021, then tumbled by 38.69% to 0.5 in 2022, then gained by 29.19% to 0.65 in 2023, then tumbled by 436.23% to 2.19 in 2024, then jumped by 116.46% to 0.36 in 2025.
• Business Quant data shows GCTK's Equity Ratio at 0.36 in Q4 2025, 0.33 in Q3 2025, and 0.67 in Q2 2025.